The emerging approach of tirzepatide peptide represents a significant breakthrough in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts two pathways – GLP-1 and GIP – leading to improved sugar management and anticipated reduction in weight. Scientists are exploring its long-term advantages and part in the complete t